Systemic therapies of pityriasis rubra pilaris: a systematic review
- 6 December 2018
- journal article
- review article
- Published by Wiley in JDDG: Journal der Deutschen Dermatologischen Gesellschaft
- Vol. 17 (3), 243-259
- https://doi.org/10.1111/ddg.13718
Abstract
Pityriasis rubra pilaris (PRP) is a rare papulosquamous disorder. Treatment is challenging; the armamentarium consists of topical corticosteroids, phototherapy, classic systemic treatments such as retinoids or immunosuppressive drugs, and most recently biologicals. However, the relative effectiveness of therapies is unclear. Our objective was to review the published literature on systemic treatment of PRP. A systematic review was conducted on PubMed and the Cochrane Library up to 5 September 2017. Studies evaluating any systemic treatments of PRP (except for historical treatments) were included. Overall, 182 studies met the predefined inclusion criteria, and reported on 475 patients and 652 courses of treatment. 42.0 % (225/514) of all patients treated with retinoids achieved an excellent response (isotretinoin: 61.1 % [102/167], etretinate: 47 % [54/115], and acitretin: 24.7 % [43/174]) compared to an excellent response rate of 33.1 % (53/160) with methotrexate. Therapy with biologicals was successful in 51.0 % of patients (71/133) (ustekinumab: 62.5 % [10/16], infliximab: 57.1 % [28/49], etanercept: 53.3 % [16/30], and adalimumab: 46.4 % [13/28]). This review balances effectiveness, side effects, experience, and drug costs in order to suggest a treatment regimen starting with isotretinoin as first-line, methotrexate as second-line and biologicals as third-line treatment for this difficult-to-treat dermatosis.This publication has 155 references indexed in Scilit:
- Long-term ustekinumab treatment for refractory type I pityriasis rubra pilarisJournal of Dermatological Case Reports, 2013
- Oral Alitretinoin for the Treatment of Recalcitrant Pityriasis Rubra PilarisCase Reports in Dermatology, 2011
- Pityriasis rubra pilaris presenting with an abnormal autoimmune profile: two case reportsJournal of Medical Case Reports, 2009
- Treatment of juvenile pityriasis rubra pilaris with etanerceptJournal of the American Academy of Dermatology, 2008
- Infliximab monotherapy as first-line treatment for adult-onset pityriasis rubra pilaris: Case report and review of the literature on biologic therapyJournal of the American Academy of Dermatology, 2008
- Treatment of classic pityriasis rubra pilarisJournal of the American Academy of Dermatology, 1994
- Retinoid hepatitisJournal of the American Academy of Dermatology, 1993
- Acitretin in the treatment of severe disorders of keratinization: Results of an open studyJournal of the American Academy of Dermatology, 1991